Metys Pharmaceuticals is developing dimiracetam for the prevention of chemotherapy-induced painful peripheral neuropathy. In the US alone, in a single year, more than 400'000 patients suffer from the neuropathy caused by their life-saving cancer treatment. No drug has been approved to prevent or treat this condition. Dimiracetam is an orally active, small molecule with more than 200 patients' safety and tolerability data; dimiracetam is highly effective in preventing and treating chemotherapy-induced neuropathy in rodents. Metys Pharmaceuticals is preparing the first dedicated efficacy study of dimiracetam in this indication.
Company Details
- Employees
- 2
- Founded
- 2013
- Address
- Leimenstrasse 57, Basel,basel City 4051,switzerland
- Phone
- 41794087972
- in****@****arma.ch
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- metys-pharma.ch
- Keywords
- Drug development.
- HQ
- Basel, Basel City
Metys Pharmaceuticals Questions
Metys Pharmaceuticals's helpline number is 41794087972
Metys Pharmaceuticals's website is metys-pharma.ch
Metys Pharmaceuticals's LinkedIn profile is https://ch.linkedin.com/company/metys-pharma
Metys Pharmaceuticals has
2 employees.
View email and phone details for 2
employees at Metys Pharmaceuticals.
Metys Pharmaceuticals's industry is
Pharmaceutical Manufacturing
Metys Pharmaceuticals's top competitors are
Teva Pharmaceuticals,
Mepha / Teva Switzerland,
Stratpharma,
Idorsia Pharmaceuticals Ltd,
Rhizen Pharmaceuticals Ag,
Novaremed Ag,
Noorik Biopharmaceuticals Ag,
Amyra Biotech Ag,
Altamira Therapeutics,
Drossapharm.
Metys Pharmaceuticals's support email address is info@metys-pharma.ch
Metys Pharmaceuticals's categories are Pharmaceutical Manufacturing
Metys Pharmaceuticals's founding year is 2013
